View of The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors

Return to Article Details The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Estrogen Receptor-Positive,Human Epidermal Growth Factor Receptor 2 (HER2)—Negative Metastatic Breast Cancer Breast Cancer Treated with CDK4/6 inhibitors Download Download PDF